ArticleInfluenza and other respiratory viruses2025
Changing Epidemiological Pattern and Higher Disease Burden of Influenza in China, 2022 to 2025.
Article in Influenza and other respiratory viruses, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Evolution of swine influenza surveillance and one health governance in Taiwan: from zoonotic risk management to integrated preparedness.Veterinary research communications · 2026Review
- Suppression and resurgence: the evolving epidemiology of seasonal influenza from 2015 to 2024 in a core urban district of Beijing, China.Frontiers in public health · 2026Article
- Comparative analysis of influenza epidemiological characteristics in Quzhou, China from 2016 to 2024.Annals of medicine · 2025Article
- Changing Epidemiological Pattern and Higher Disease Burden of Influenza in China, 2022 to 2025.Influenza and other respiratory viruses · 2025Article
- Pediatric early warning score and unplanned readmission with influenza at emergency observation room.Frontiers in pediatrics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Influenza activity peaks in southern (59.62%) and northern China (57.60%) during the 2022/2023 season reached the highest levels in the past 10 years. The 2023/2024 season witnessed a longer duration of the winter-spring epidemic weeks and a higher disease burden compared with previous high-epidemic years. The A(H3N2), A(H1N1)pdm09, and B/Victoria lineages alternated among the predominant circulating strains from the 2022/2023 season to the 2024/2025 season. After the 2022/2023 and 2023/2024 seasons of disruption and fluctuation, influenza in the 2024/2025 season has reverted to its previous epidemic pattern.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.